ABCC7 p.Ser1118Phe
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 11124965
[PubMed]
Kogan I et al: "Perturbation of the pore of the cystic fibrosis transmembrane conductance regulator (CFTR) inhibits its atpase activity."
No.
Sentence
Comment
176
With regards to CFTR, there is indirect evidence supporting interaction between permeation and gating, in that certain mutations in the transmembrane segments of CFTR, namely S1118F in TM11 (33) and the disease-causing mutant R117H (50), exhibit altered channel open times.
X
ABCC7 p.Ser1118Phe 11124965:176:175
status: NEW
PMID: 11179391
[PubMed]
Linsdell P et al: "Relationship between anion binding and anion permeability revealed by mutagenesis within the cystic fibrosis transmembrane conductance regulator chloride channel pore."
No.
Sentence
Comment
254
Interestingly, S1118 in TM11 has been suggested to occupy a position similar to that of T338 in TM6, and the mutations S1118A and S1118F cause small alterations in anion permeability (Zhang et al. 2000).
X
ABCC7 p.Ser1118Phe 11179391:254:130
status: NEW
PMID: 11380256
[PubMed]
Gupta J et al: "Asymmetric structure of the cystic fibrosis transmembrane conductance regulator chloride channel pore suggested by mutagenesis of the twelfth transmembrane region."
No.
Sentence
Comment
187
A point mutation in TM11 (S1118F) was recently shown to cause a dramatic reduction in mean channel open burst duration, implying a decrease in the stability of the channel open state (42).
X
ABCC7 p.Ser1118Phe 11380256:187:26
status: NEW
PMID: 15711774
[PubMed]
Zhang ZR et al: "Time-dependent interactions of glibenclamide with CFTR: kinetically complex block of macroscopic currents."
No.
Sentence
Comment
300
Unblocked macroscopic currents in WT-CFTR and nearly all mutants studied to date are time-independent (exceptions are S1118F-CFTR and V317E-CFTR, which confer voltage-jump relaxations on currents in the absence of added blockers; Zhang, McDonough & McCarty, 2000b; Zhang et al. 2002).
X
ABCC7 p.Ser1118Phe 15711774:300:118
status: NEW
PMID: 19381710
[PubMed]
Fatehi M et al: "Novel residues lining the CFTR chloride channel pore identified by functional modification of introduced cysteines."
No.
Sentence
Comment
201
Previously, SCN- permeabil- ity was shown to be significantly decreased in S1118F but unaltered in S1118A (Zhang et al. 2000).
X
ABCC7 p.Ser1118Phe 19381710:201:75
status: NEW
No.
Sentence
Comment
8
Results: S1118F-CFTR makes less than 10-15% of mature CFTR (band C) compared to WT-CFTR.
X
ABCC7 p.Ser1118Phe 19774621:8:9
status: NEW9 The mRNA levels of S1118F-CFTR and WT-CFTR are comparable.
X
ABCC7 p.Ser1118Phe 19774621:9:19
status: NEW10 S1118F-CFTR is functional but shows about 10-15% of WT-CFTR activity.
X
ABCC7 p.Ser1118Phe 19774621:10:0
status: NEW11 S1118F-CFTR shows impaired maturation and CF-correctors can increase the amount of mature and functional CFTR by three- to fourfold.
X
ABCC7 p.Ser1118Phe 19774621:11:0
status: NEW12 Conclusion: S1118F-CFTR shows impaired maturation and an individual with S1118F-CFTR paired with DF508-CFTRexhibits atypical CF symptomswith intermediate sweat chloride level and meconium ileus despite documented pancreatic sufficiency.
X
ABCC7 p.Ser1118Phe 19774621:12:12
status: NEWX
ABCC7 p.Ser1118Phe 19774621:12:73
status: NEW39 This class of mutations includes C-terminal truncated CFTR which form unstable mature protein with five- to sixfold faster degradation rate than WT-CFTR.2-7 We present herein a clinical case of a CF patient with intermediate sweat chloride levels, pancreatic sufficiency, meconium ileus and mutations in the CFTR gene (DF508 and S1118F).
X
ABCC7 p.Ser1118Phe 19774621:39:329
status: NEW40 The objective of this study is to characterize S1118F-CFTR mutation at protein level to help understand the associated CF-phenotype.
X
ABCC7 p.Ser1118Phe 19774621:40:47
status: NEW42 MATERIALS AND METHODS Genotyping Genotyping was performed at Ambry Genetics (Aliso Viejo, CA) which showed DF508/I1027Ton one chromosome and S1118F on the other.
X
ABCC7 p.Ser1118Phe 19774621:42:141
status: NEW45 Site-directed mutagenesis was performed by a single point mutation in eukaryotic expression vector (pcDNA3) containing WT-CFTR cDNA using Quikchange site-directed mutagenesis kit (Stratagene, La Jolla, CA) and appropriate primers to make S1118F-CFTR mutant.
X
ABCC7 p.Ser1118Phe 19774621:45:238
status: NEW50 Pulse Chase Labeling HEK-293 cells transiently transfected with WTor S1118F-CFTR cDNA were incubated in MEM medium (Invitrogen) without methionine and cysteine for 60 min at 378C.
X
ABCC7 p.Ser1118Phe 19774621:50:69
status: NEW56 Probe designed by Universal ProbeLibrary (Roche, Indianapolis, IN) was used and TATA-box binding protein (TBP) was used as the house keeping gene.10 Iodide Efflux HEK-293 cells were transfected with 2 mg of pcDNA3 WT-CFTR, pcDNA3 S1118F-CFTR or empty vector (pcDNA3) cDNA.
X
ABCC7 p.Ser1118Phe 19774621:56:230
status: NEW65 RESULTS An Individual Harboring S1118F-CFTR Exhibits Atypical CF Symptoms A Caucasian infant was born at 376=7 weeks by cesarean section in Mississippi (USA).
X
ABCC7 p.Ser1118Phe 19774621:65:32
status: NEW72 Genotyping was sent to Ambry Genetics which showed DF508/I1027T on one chromosome and S1118F on the other.
X
ABCC7 p.Ser1118Phe 19774621:72:86
status: NEW81 S1118F-CFTR Makes Less Than 10-15% of Mature CFTR (band C) Compared to WT-CFTR Previous studies in Xenopus oocytes have shown that S1118F-CFTR is a mutant with altered permeation and gating characteristics compared to WT-CFTR.14 It is therefore likely that this mutant belongs to Class IV CFTR mutations.
X
ABCC7 p.Ser1118Phe 19774621:81:0
status: NEWX
ABCC7 p.Ser1118Phe 19774621:81:131
status: NEW83 Using Quickchange method, we generated S1118F mutation on pcDNA3-CFTR background.
X
ABCC7 p.Ser1118Phe 19774621:83:39
status: NEW87 The data shows that S1118F-CFTR appears as a 180 kDa immunoreactive band (band C; the mature CFTR) but is less than 10-15% of that for WT-CFTR (Fig. 1A).
X
ABCC7 p.Ser1118Phe 19774621:87:20
status: NEW89 Iodide efflux measurements were performed using HEK-293 cells transiently transfected with WTor S1118F-CFTR cDNA.
X
ABCC7 p.Ser1118Phe 19774621:89:96
status: NEW90 As shown in Figure 1B and C, S1118F-CFTR is functional but has much lower activity (10-15%) compared to WT-CFTR.
X
ABCC7 p.Ser1118Phe 19774621:90:29
status: NEW92 In an attempt to define which class this mutation might belong to, we compared S1118F-CFTR with other well-defined classes of CFTR-mutations such as DF508-CFTR (Class II), G551D-CFTR (Class III) and R117H-CFTR (Class IV) and the data is shown in Figure 1D. It is likely that S1118F-CFTR is a trafficking mutant with impaired maturation.
X
ABCC7 p.Ser1118Phe 19774621:92:79
status: NEWX
ABCC7 p.Ser1118Phe 19774621:92:275
status: NEW93 S1118F-CFTR Shows Impaired Maturation To test if the reduced expression level of S1118F-CFTR is due to reduced maturation efficiency, we performed pulse chase experiments by treating HEK293 cells expressing S1118F-CFTR or WT-CFTR with a brief pulse for 30 min.
X
ABCC7 p.Ser1118Phe 19774621:93:0
status: NEWX
ABCC7 p.Ser1118Phe 19774621:93:81
status: NEWX
ABCC7 p.Ser1118Phe 19774621:93:207
status: NEW96 However, the maturation is not efficient for S1118F-CFTR and only a small portion of band B was converted to band C (impaired maturation).
X
ABCC7 p.Ser1118Phe 19774621:96:45
status: NEW97 These biochemical studies are consistent with a mild CF-phenotype observed for individuals harboring S1118F-CFTR as it is a trafficking mutant with impaired maturation efficiency.
X
ABCC7 p.Ser1118Phe 19774621:97:101
status: NEW98 To investigate if S1118F-CFTR mRNA has reduced stability, real-time PCR was performed to compare mRNA Pediatric Pulmonology expression levels in HEK-293 cells transfected with equal amounts of WTor S1118F-CFTR cDNA.
X
ABCC7 p.Ser1118Phe 19774621:98:18
status: NEWX
ABCC7 p.Ser1118Phe 19774621:98:199
status: NEW99 The results showed that the mRNA expression level for S1118F-CFTR is not reduced compared to WT-CFTR (Fig. 3).
X
ABCC7 p.Ser1118Phe 19774621:99:54
status: NEW100 It is therefore reasonable to propose that S1118F-CFTR does not belong to the class V mutations.
X
ABCC7 p.Ser1118Phe 19774621:100:43
status: NEW101 CF-Correctors Can Increase the Amount and Function of S1118F-CFTR Several Folds To test if S1118F-CFTR can be rescued by using CF-correctors, HEK-293 cells expressing WTor S1118F-CFTR was incubated with CF-corrector C1 [6-(1H- benzomidazol-2-ylsulfanylmethyl)-2-(6-methoxy-4-methyl- quinazolin-2-ylamino)-pyrimidin-4-ol] or C3 [(4-cyclohexyloxy-2-{1-[4-(4-methoxy-benzensulfonyl)-piperazin- 1-yl]-ethyl}-quinazoline], lysed, immunoprecipitated and probed for CFTR.
X
ABCC7 p.Ser1118Phe 19774621:101:54
status: NEWX
ABCC7 p.Ser1118Phe 19774621:101:91
status: NEWX
ABCC7 p.Ser1118Phe 19774621:101:172
status: NEW102 The result showed that treatment of HEK-293 cells expressing S1118F-CFTR with these CF-correctors did increase the mature form of CFTR.
X
ABCC7 p.Ser1118Phe 19774621:102:61
status: NEW105 Iodide efflux experiments were performed by using HEK-293 cells expressing S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 19774621:105:75
status: NEW106 As shown in Figure 4B,C, in the presence of CF-Corrector C3, the function of S1118F-CFTR increases two- to fourfold.
X
ABCC7 p.Ser1118Phe 19774621:106:77
status: NEW107 This result is consistent with the Western Blotting result suggesting that S1118F-CFTR mutant can be functionally rescued by using CF-correctors.
X
ABCC7 p.Ser1118Phe 19774621:107:75
status: NEW108 DISCUSSION S1118F-CFTR is a serine-to-phenylalanine mutation in the 11th transmembrane-spanning domain (TMD) of Pediatric Pulmonology Fig. 1.
X
ABCC7 p.Ser1118Phe 19774621:108:11
status: NEW109 Characterization of S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 19774621:109:20
status: NEW110 A: HEK-293 cells were transiently transfected with pcDNA3 containing WT-, S1118F- or DF508-CFTR cDNA, lysed after 48 hr, immunoprecipitated and western blotted for CFTR (a 24-1 mab).
X
ABCC7 p.Ser1118Phe 19774621:110:74
status: NEW111 The experiments were performed 4 times. B: Iodide efflux assay in HEK-293 cells transiently transfected with WTor S1118F-CFTR cDNA.
X
ABCC7 p.Ser1118Phe 19774621:111:114
status: NEW112 PKA activating agonist cocktail (containing 10 mM forskolin, 100 mM IBMX and 200 mM cpt-cAMP) was added to activate CFTR. Line graph is Iodide efflux (nmol/min) as mean of 3 (WT and Control) or 5 (S1118F-CFTR) experiments with standard error mean (SEM).
X
ABCC7 p.Ser1118Phe 19774621:112:197
status: NEW114 D: HEK-293cells weretransiently transfected with pCDNA3 containing WT-, S1118F-, R117H-, G551D- or DF508-CFTR cDNA, lysed 48 hr later, immunoprecipitated (a 24-1 mab) and western blotted for CFTR (a 24-1 mab).
X
ABCC7 p.Ser1118Phe 19774621:114:72
status: NEW119 expressed S1118F-CFTR mutant in stage V Xenopus oocytes and studied the channel properties electrophysiologically.
X
ABCC7 p.Ser1118Phe 19774621:119:10
status: NEW122 S1118F-CFTR shows impaired maturation.
X
ABCC7 p.Ser1118Phe 19774621:122:0
status: NEW123 A: Pulse-chase experiments to monitor the formation of mature protein over a period of 2 hr in HEK-293 cells transfected with WTor S1118F-CFTR cDNA.
X
ABCC7 p.Ser1118Phe 19774621:123:131
status: NEW124 The experiments were performed 4 times. B: Quantitation of mature(band C) andimmature (bandB) protein in WTand S1118F-CFTR from pulse-chase experiment showing impaired maturation of S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 19774621:124:111
status: NEWX
ABCC7 p.Ser1118Phe 19774621:124:113
status: NEW125 The band B at time ''0`` was considered as 100% for WTand S1118F-CFTR, respectively.
X
ABCC7 p.Ser1118Phe 19774621:125:58
status: NEW127 Real-time PCR for comparing mRNA expression levels in HEK-293 cells transfected with equal amounts of WTand S1118F-CFTR cDNA.
X
ABCC7 p.Ser1118Phe 19774621:127:108
status: NEW129 The change in relative expression levels between WT-CFTR and S1118F-CFTR was found to be insignificant.
X
ABCC7 p.Ser1118Phe 19774621:129:61
status: NEW132 CF-correctors can increase the amount and function of S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 19774621:132:54
status: NEW134 The experiments were repeated for 4 times. B: Iodide efflux assay in HEK-293 cells transiently transfected with S1118F-CFTR with or without CF-corrector C3 treatment (5 mM).
X
ABCC7 p.Ser1118Phe 19774621:134:112
status: NEW142 To help understand this mild CF-phenotype, we used various biochemical methods to characterize S1118F-CFTR mutant at protein level.
X
ABCC7 p.Ser1118Phe 19774621:142:95
status: NEW146 Secondly, to investigate if S1118F-CFTR is functional (as a ClÀ channel), we performed iodide efflux experiments.
X
ABCC7 p.Ser1118Phe 19774621:146:28
status: NEW147 The result showed S1118F-CFTR is functional but has much lower activity compared to WT-CFTR (Fig. 1B,C).
X
ABCC7 p.Ser1118Phe 19774621:147:18
status: NEW148 This functional result is consistent with the protein expression data and with Zhang`s result which showed S1118F-CFTR is a functional ClÀ channel yet with altered permeation and gating characteristics compared to WT-CFTR.14 Thirdly, we compared S1118F-CFTR with other well-defined CF-mutations using Western blotting.
X
ABCC7 p.Ser1118Phe 19774621:148:107
status: NEWX
ABCC7 p.Ser1118Phe 19774621:148:251
status: NEW150 Based on the observations as described above and Zhang`s result,14 it is therefore reasonable to assume that S1118F-CFTR might be a trafficking mutant with impaired maturation.
X
ABCC7 p.Ser1118Phe 19774621:150:109
status: NEW151 Pulse chase experiments were employed to test the maturation efficiency of S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 19774621:151:75
status: NEW153 Next, to investigate if the impaired maturation is due to the reduced mRNA stability, we performed real-time PCR to compare mRNA expression levels in HEK293 cells transfected with equal amounts of WTor S1118F-CFTR cDNA.
X
ABCC7 p.Ser1118Phe 19774621:153:202
status: NEW154 The results showed that the mRNA expression level for S1118F-CFTR is not reduced compared to WT-CFTR suggesting that S1118F-CFTR does not belong to class V mutations (Fig. 3).
X
ABCC7 p.Ser1118Phe 19774621:154:54
status: NEWX
ABCC7 p.Ser1118Phe 19774621:154:117
status: NEW158 The use of pharmacological chaperones (CF-correctors) to promote the maturation of such mutants is one of the promising approaches.19-22 To test if the maturation efficiency for S1118F-CFTR can be improved by using CF-correctors, we treated HEK-293 cells expressing S1118F-CFTR with CF-correctors C1 and C3.
X
ABCC7 p.Ser1118Phe 19774621:158:178
status: NEWX
ABCC7 p.Ser1118Phe 19774621:158:266
status: NEW160 In the presence of CF-corrector C3, the mature band C increased by three- to fourfold over untreated cells and the function of S1118F-CFTR increased two- to fourfold as well in iodide efflux experiments.
X
ABCC7 p.Ser1118Phe 19774621:160:127
status: NEW161 Consistent with a mild CF-phenotype observed for a patient, our studies suggest that S1118F-CFTR is likely to be trafficking mutant with impaired maturation.
X
ABCC7 p.Ser1118Phe 19774621:161:85
status: NEW163 To our knowledge, this is the first study in which S1118F-CFTR mutant was fully characterized at the protein level.
X
ABCC7 p.Ser1118Phe 19774621:163:51
status: NEW
PMID: 23056764
[PubMed]
Dooki MR et al: "Detecting Common CFTR Mutations by Reverse Dot Blot Hybridization Method in Cystic Fibrosis First Report from Northern Iran."
No.
Sentence
Comment
234
Penmatsa H, Frederick CA, Nekkalapu S, et al. Clinical and molecular characterization of S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 23056764:234:89
status: NEW237 Penmatsa H, Frederick CA, Nekkalapu S, et al. Clinical and molecular characterization of S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 23056764:237:89
status: NEW
PMID: 10866956
[PubMed]
Zhang ZR et al: "Interaction between permeation and gating in a putative pore domain mutant in the cystic fibrosis transmembrane conductance regulator."
No.
Sentence
Comment
2
Here we report a serine-to-phenylalanine mutation (S1118F) in the 11th transmembrane domain that confers voltage-dependent, single-exponential current relaxations and moderate inward rectification of the macroscopic currents upon expression in Xenopus oocytes.
X
ABCC7 p.Ser1118Phe 10866956:2:51
status: NEW3 At steady state, the S1118F-CFTR single-channel conductance rectifies, corresponding to the whole-cell rectification.
X
ABCC7 p.Ser1118Phe 10866956:3:21
status: NEW5 S1118F-CFTR currents are blocked in a voltage-dependent manner by diphenylamine-2-carboxylate (DPC); the affinity of S1118F-CFTR for DPC is similar to that of the wild-type channel, but blockade exhibits moderately reduced voltage dependence.
X
ABCC7 p.Ser1118Phe 10866956:5:0
status: NEWX
ABCC7 p.Ser1118Phe 10866956:5:117
status: NEW22 Here we report a serine-to-phenylalanine mutation (S1118F) in TM11 that affects both permeation and gating.
X
ABCC7 p.Ser1118Phe 10866956:22:51
status: NEW23 Most strikingly, the macroscopic S1118F-CFTR currents display voltage-dependent current relaxations; these relaxations are modulated by permeating anions.
X
ABCC7 p.Ser1118Phe 10866956:23:33
status: NEW33 Preparation of oocytes and cRNA CFTR was subcloned into the pALTER vector (Promega), and the S1118F, S1118A, and S1118F/F1111S mutations were made using the Promega Altered Sites protocol (McDonough et al., 1994).
X
ABCC7 p.Ser1118Phe 10866956:33:93
status: NEWX
ABCC7 p.Ser1118Phe 10866956:33:113
status: NEW80 Unexpectedly, the most obvious consequence of the mutation of S1118F-CFTR is the appearance of relaxations in current density upon stepping to a new membrane potential.
X
ABCC7 p.Ser1118Phe 10866956:80:62
status: NEW85 However, S1118F-CFTR displays voltage-dependent current relaxations in response to protocols applying either depolarizing or hyperpolarizing prepotentials.
X
ABCC7 p.Ser1118Phe 10866956:85:9
status: NEW87 These voltage-jump relaxations lead to a larger conductance for jumps to more negative potentials and to a smaller conductance for jumps in the FIGURE 1 Mutation S1118F-CFTR results in current relaxations.
X
ABCC7 p.Ser1118Phe 10866956:87:162
status: NEW93 (B and C) Families of currents measured in oocytes expressing either wild-type or S1118F-CFTR channels, respectively.
X
ABCC7 p.Ser1118Phe 10866956:93:82
status: NEW104 Note that S1118F-CFTR also displays tail currents (Figs. 1, 2, 6, and 7), which have not been described for WT or any mutant of CFTR studied thus far.
X
ABCC7 p.Ser1118Phe 10866956:104:10
status: NEW116 In WT-CFTR, TM11 contains four phenylalanine residues (Fig. 1 A); mutation of S1118F adds a fifth.
X
ABCC7 p.Ser1118Phe 10866956:116:78
status: NEW117 If this domain is ॷ-helical, as predicted from hydropathy analysis (Riordan et al., 1989), mutation S1118F would then place three phenylalanine residues in close mutual proximity (at positions 1107, 1111, and 1118) and on approximately the same face of the helix.
X
ABCC7 p.Ser1118Phe 10866956:117:106
status: NEW118 To determine whether this imposed pattern was the source of relaxations in S1118F-CFTR, due to introduction of another bulky residue, the double mutation S1118F/F1111S was constructed.
X
ABCC7 p.Ser1118Phe 10866956:118:75
status: NEWX
ABCC7 p.Ser1118Phe 10866956:118:154
status: NEW119 These channels displayed relaxations indistinguishable from those of the single FIGURE 2 Relaxations induced in S1118F-CFTR currents were fit to single-exponential decay functions.
X
ABCC7 p.Ser1118Phe 10866956:119:112
status: NEW126 mutant S1118F-CFTR (not shown).
X
ABCC7 p.Ser1118Phe 10866956:126:7
status: NEW132 Gating behavior of single CFTR channels from oocytes expressing WT or S1118F-CFTR was studied in excised patch mode.
X
ABCC7 p.Ser1118Phe 10866956:132:70
status: NEW139 Under these conditions, burst duration was 1392 afe; 77 ms for WT-CFTR (n afd; 441 bursts) and 102 afe; 8 ms for S1118F- FIGURE 3 The current-voltage relations for S1118F-CFTR channel shift during the voltage-jump relaxations.
X
ABCC7 p.Ser1118Phe 10866956:139:122
status: NEWX
ABCC7 p.Ser1118Phe 10866956:139:173
status: NEW152 Note that S1118F-CFTR channels exhibit much briefer openings than does WT.
X
ABCC7 p.Ser1118Phe 10866956:152:10
status: NEW153 Currents were not observed in phosphorylated WT or S1118F-CFTR channels bathed in solutions lacking ATP (not shown).
X
ABCC7 p.Ser1118Phe 10866956:153:51
status: NEW155 Hence the mean burst duration in S1118F-CFTR is reduced to only 7% that of WT channels.
X
ABCC7 p.Ser1118Phe 10866956:155:33
status: NEW166 We tested whether S1118F-CFTR exhibited alterations in the interaction with DPC, which would be consistent with a pore-lining position for this serine.
X
ABCC7 p.Ser1118Phe 10866956:166:18
status: NEW167 Fig. 6 shows background-subtracted S1118F-CFTR currents for a representative cell before (Fig. 6 A) and several minutes after (Fig. 6 B) bath application of 200 òe;M DPC.
X
ABCC7 p.Ser1118Phe 10866956:167:35
status: NEW171 At afa;100 mV, DPC blocks S1118F-CFTR and WT channels with roughly the same efficacy: the apparent KD (at afa;100 mV) was, respectively, 266 afe; 13 òe;M and 276 afe; 14 òe;M (mean afe; SE, n afd; 6 and 15; data for WT are from McDonough et al., 1994).
X
ABCC7 p.Ser1118Phe 10866956:171:29
status: NEW174 The voltage dependence of the S1118F-CFTR block is significantly less steep than that of the wild type; the apparent binding distance is òa; afd; 0.27 afe; 0.01 (mean afe; SE, n afd; 6) for the mutant versus 0.41 afe; 0.03 for WT channels (McDonough et al., 1994).
X
ABCC7 p.Ser1118Phe 10866956:174:30
status: NEW175 S1118F-CFTR exhibits altered permeation characteristics S1118, according to our alignment, occupies a position in TM11 that is homologous to that of T338 in TM6.
X
ABCC7 p.Ser1118Phe 10866956:175:0
status: NEW179 Because oocytes expressing S1118F-CFTR show voltage-jump relaxations, it was not appropriate to use the more common approach of applying voltage-ramp protocols to generate selectivity data.
X
ABCC7 p.Ser1118Phe 10866956:179:27
status: NEW180 Instead, currents in oocytes expressing WT-, S1118F-, or S1118A-CFTR channels were elicited by stepping for 75 ms from the holding potential of afa;30 mV to a series of test potentials between afa;140 and af9;80 mV in af9;20 mV increments.
X
ABCC7 p.Ser1118Phe 10866956:180:45
status: NEW182 If there are two open states that vary in the voltage dependence of microscopic kinetics, currents measured early in the relaxation and at later times likely represent different mixtures of FIGURE 5 S1118F-CFTR channels show rectification of single-channel conductance.
X
ABCC7 p.Ser1118Phe 10866956:182:199
status: NEW189 Hence currents at each potential were averaged over two time periods: either the first FIGURE 6 Mutation S1118F has mild effects on blockade by DPC.
X
ABCC7 p.Ser1118Phe 10866956:189:105
status: NEW204 (B) Currents in S1118F-CFTR-expressing oocytes, showing pronounced relaxations at depolarizing test potentials.
X
ABCC7 p.Ser1118Phe 10866956:204:16
status: NEW207 Note the prominent tail currents in S1118F-CFTR but not in WT.
X
ABCC7 p.Ser1118Phe 10866956:207:36
status: NEW235 Data are shown for both instantaneous currents and steady-state currents for WT and S1118F-CFTR (Fig. 8, A and B) or S1118A-CFTR (Fig. 8, C and D).
X
ABCC7 p.Ser1118Phe 10866956:235:84
status: NEW236 In Clafa; -containing solutions, before anion substitutions were made, there was a significant difference (p afd; 0.047) between instantaneous and steady-state reversal potentials in S1118F-CFTR (Table 2) compared to the WT (Table 1), but not in S1118A-CFTR.
X
ABCC7 p.Ser1118Phe 10866956:236:189
status: NEW237 This suggests that S1118F-CFTR channels may be less Clafa; -selective than are WT channels.
X
ABCC7 p.Ser1118Phe 10866956:237:19
status: NEW238 Comparing the selectivity pattern in S1118F-CFTR with that of WT, without respect to time dependence, showed significant changes for both relative permeabilities and relative conductances (compare Tables 1 and 2).
X
ABCC7 p.Ser1118Phe 10866956:238:37
status: NEW239 The ability of the large anions (acetate, gluconate, glutamate, and isethionate) to gain access to the pore is altered by mutations S1118A and S1118F, as indicated by mild to significant changes in relative permeabilities for these anions compared to that in WT channels.
X
ABCC7 p.Ser1118Phe 10866956:239:143
status: NEW246 Accordingly, GX/GCl in S1118F-CFTR showed dramatic changes for seven of the nine test anions (Fig. 8 B).
X
ABCC7 p.Ser1118Phe 10866956:246:23
status: NEW247 Relative conductances for the large anions were altered substantially in the S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 10866956:247:77
status: NEW249 S1118F-CFTR also exhibited less block by iodide and thiocyanate, consistent with disruption of the high-affinity binding of these anions in the WT pore.
X
ABCC7 p.Ser1118Phe 10866956:249:0
status: NEW250 Relative conductances were generally less affected in S1118A-CFTR than in S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 10866956:250:74
status: NEW252 FIGURE 8 Selectivity data for WT CFTR as compared to S1118F-CFTR (A and B) and S1118A-CFTR (C and D).
X
ABCC7 p.Ser1118Phe 10866956:252:53
status: NEW260 &#a7; p b0d; 0.01 for S1118F-CFTR or p afd; 0.02 for S1118A-CFTR.
X
ABCC7 p.Ser1118Phe 10866956:260:25
status: NEW263 Nor does relative permeability for S1118F-CFTR (Fig. 8 A) or S1118A-CFTR (Fig. 8 C) show any time dependence.
X
ABCC7 p.Ser1118Phe 10866956:263:35
status: NEW264 However, relative conductances for the largest anions studied (gluconate and glutamate) decreased in S1118F-CFTR during the 75-ms voltage jump (Fig. 8 B;&#a7; indicates p b0d; 0.01).
X
ABCC7 p.Ser1118Phe 10866956:264:101
status: NEW265 Because these effects in S1118F-CFTR were only found for the largest anions tested, we propose that this result signifies a time-dependent change in the diameter of the narrowest part of the pore. We would expect this difference to be magnified in experiments in which Clafa; was replaced entirely with glutamate or gluconate (Khakh and Lester, 1999).
X
ABCC7 p.Ser1118Phe 10866956:265:25
status: NEW269 Fig. 9 shows the current-voltage relations in the presence of chloride and glutamate for one representative experiment in S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 10866956:269:122
status: NEW274 Based upon the following observations, we reasoned that there may be a structural connection between the changes in permeation properties of S1118F-CFTR and the process underlying the voltage jump relaxations: 1) The change in permeation properties after a voltage jump (Figs. 1 and 9) is consistent with the steady-state kinetics of single channels (Fig. 5).
X
ABCC7 p.Ser1118Phe 10866956:274:141
status: NEW278 To address this issue, we asked whether there is any interaction between permeation and gating in S1118F-CFTR channels studied under whole-cell conditions.
X
ABCC7 p.Ser1118Phe 10866956:278:98
status: NEW280 Current-voltage relations in chloride and glutamate for instantaneous currents (--) and steady-state currents (- - -) in S1118F-CFTR were adjusted on the voltage axis so that their reversal potentials were set to zero.
X
ABCC7 p.Ser1118Phe 10866956:280:121
status: NEW284 TABLE 2 Selectivity in S1118F-CFTR and S1118A-CFTR Ion S1118F S1118A Erev (mV) PX/PCl GX/GCl Erev (mV) PX/PCl GX/GCl SCN afa;40.97 afe; 1.20* 1.84 afe; 0.08* 0.57 afe; 0.02* afa;56.44 afe; 0.93 2.59 afe; 0.09 0.20 afe; 0.01 NO3 afa;32.83 afe; 1.69 1.30 afe; 0.06 0.95 afe; 0.02 afa;37.35 afe; 0.87 1.21 afe; 0.04 0.88 afe; 0.01 Br afa;28.28 afe; 1.32 1.07 afe; 0.03 0.88 afe; 0.03* afa;34.53 afe; 0.85 1.12 afe; 0.02 0.77 afe; 0.01 Cl afa;26.14 afe; 1.59* 1.0 1.0 afa;30.63 afe; 0.64 1.0 1.0 I afa;8.46 afe; 1.14 0.52 afe; 0.03* 0.38 afe; 0.03* afa;10.35 afe; 1.26 0.39 afe; 0.01 0.27 afe; 0.05 Acetate 39.64 afe; 1.77* 0.05 afe; 0.01* 0.12 afe; 0.01* 23.24 afe; 1.83* 0.09 afe; 0.01* 0.50 afe; 0.01* Glutamate 23.93 afe; 3.61* 0.16 afe; 0.01* 0.23 afe; 0.01* 19.59 afe; 1.07* 0.09 afe; 0.01* 0.49 afe; 0.01* 0.32 afe; 0.01I * Isethionate 20.24 afe; 3.62* 0.14 afe; 0.03 0.25 afe; 0.02* 23.71 afe; 0.99* 0.09 afe; 0.01* 0.48 afe; 0.01 ClO4 afa;6.42 afe; 1.57* 0.42 afe; 0.02* 0.18 afe; 0.01 27.29 afe; 1.36* 0.06 afe; 0.01* 0.12 afe; 0.01* 0.14 afe; 0.01I * Gluconate 28.26 afe; 3.29* 0.12 afe; 0.02 0.20 afe; 0.01* 20.03 afe; 1.04* 0.10 afe; 0.01* 0.50 afe; 0.01* 0.27 afe; 0.01I * Ions are listed in the same order as in Table 1.
X
ABCC7 p.Ser1118Phe 10866956:284:23
status: NEWX
ABCC7 p.Ser1118Phe 10866956:284:55
status: NEW288 WT or S1118F-CFTR channels were studied using the same voltage-clamp protocol as the one used for the data shown in Fig. 7.
X
ABCC7 p.Ser1118Phe 10866956:288:6
status: NEW295 S1118F-CFTR currents showed a relaxation as expected from previous experiments (Figs. 1, 2, and 7).
X
ABCC7 p.Ser1118Phe 10866956:295:0
status: NEW298 Because SCNafa; blocks mutant channels as it does WT channels (Table 2), we would expect the time constant for S1118F-CFTR channels in the presence of SCNafa; to be reduced as it is for WT channels.
X
ABCC7 p.Ser1118Phe 10866956:298:114
status: NEW299 In contrast, the relaxations in S1118F-CFTR were slowed by this less permeant anion such that the process underlying the relaxations was not complete even by the end of the 75-ms voltage jump.
X
ABCC7 p.Ser1118Phe 10866956:299:32
status: NEW304 In summary, the lengthening of the gating process at positive potentials in S1118F-CFTR follows the relative conductance sequence.
X
ABCC7 p.Ser1118Phe 10866956:304:76
status: NEW306 This implies a distinct connection between permeation and gating in S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 10866956:306:68
status: NEW314 (C) Time constants for the relaxations in WT and S1118F-CFTR channels were calculated by fitting the decay to an exponential function.
X
ABCC7 p.Ser1118Phe 10866956:314:49
status: NEW315 Shown are the time constants () for S1118F-CFTR currents recorded in bath solution containing Clafa; , Brafa; , or SCNafa; .
X
ABCC7 p.Ser1118Phe 10866956:315:43
status: NEW316 surements in S1118F-CFTR show modest current relaxations, on the order of 30%, during voltage jumps between afa;140 and af9;80 mV.
X
ABCC7 p.Ser1118Phe 10866956:316:13
status: NEW343 With respect to block by DPC, S1118F-CFTR had an effect much like that of T338A-CFTR, wherein affinity at afa;100 mV was not changed significantly but the voltage dependence was reduced.
X
ABCC7 p.Ser1118Phe 10866956:343:30
status: NEW344 The absolute difference in the apparent KD (at afa;100 mV) for DPC between wild type and S1118F-CFTR, taken by itself, is too small to conclude that residue S1118 lines the channel pore.
X
ABCC7 p.Ser1118Phe 10866956:344:92
status: NEW346 However, both S1118A-CFTR and S1118F-CFTR altered the selectivity behavior of the pore, suggesting that this position may contribute to the pore walls.
X
ABCC7 p.Ser1118Phe 10866956:346:30
status: NEW347 Relative conductances for many of the substitute anions were altered in S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 10866956:347:72
status: NEW353 Furthermore, S1118F-CFTR also exhibits a reduced single-channel conductance.
X
ABCC7 p.Ser1118Phe 10866956:353:13
status: NEW365 S1118F-CFTR single channels differ doubly from wild-type channels.
X
ABCC7 p.Ser1118Phe 10866956:365:0
status: NEW366 First, S1118F-CFTR openings are much briefer than wild-type openings (burst duration is reduced by 93%).
X
ABCC7 p.Ser1118Phe 10866956:366:7
status: NEW367 The choppy bursts of S1118F-CFTR closely resemble the bursts of mutant R117H, a mutation that causes mild cystic fibrosis (Sheppard et al., 1993).
X
ABCC7 p.Ser1118Phe 10866956:367:21
status: NEW368 Second, the single-channel conductance of S1118F-CFTR rectifies inwardly, in agreement with the steady-state rectification of macroscopic currents.
X
ABCC7 p.Ser1118Phe 10866956:368:42
status: NEW369 The rectification of single-channel steady-state conductance for S1118F-CFTR arises primarily from decreased conductance at positive potentials, because the single-channel conductances for the WT and mutant are nearly equal at afa;100 mV but differ at af9;100 mV.
X
ABCC7 p.Ser1118Phe 10866956:369:65
status: NEW371 That S1118F-CFTR has more defective conduction properties for positive current at depolarizing potentials (i.e., for inward flux of Clafa; ) suggests that the mutated residue affects the channel at a point nearer the extracellular than the cytoplasmic end of the channel.
X
ABCC7 p.Ser1118Phe 10866956:371:5
status: NEW375 The shortened openings in S1118F-CFTR may reflect a destabilization of the global protein structure rather than a specific effect on the pore.
X
ABCC7 p.Ser1118Phe 10866956:375:26
status: NEW383 The single-channel recordings confirm that S1118F-CFTR openings are interrupted to a much greater extent than wild-type openings.
X
ABCC7 p.Ser1118Phe 10866956:383:43
status: NEW389 Thus there is no reason to suspect that the relaxations are produced by voltage-dependent blocking events, and we tentatively favor the explanation that the S1118F-CFTR has altered gating kinetics.
X
ABCC7 p.Ser1118Phe 10866956:389:157
status: NEW391 Although an additional state may have been added to the kinetic scheme for S1118F-CFTR, it is also possible that an existing state has been modified.
X
ABCC7 p.Ser1118Phe 10866956:391:75
status: NEW392 For instance, it will be important to determine if the prominent voltage-dependent fast flicker in WT observed at hyperpolarizing potentials is modified by the S1118F mutation.
X
ABCC7 p.Ser1118Phe 10866956:392:162
status: NEW393 Possible mechanisms S1118F-CFTR exhibits alterations in permeation properties, as might be expected given the location of this mutation, but also exhibits alterations in single-channel gating.
X
ABCC7 p.Ser1118Phe 10866956:393:20
status: NEW397 It seems more likely that a unique process occurs for S1118F-CFTR.
X
ABCC7 p.Ser1118Phe 10866956:397:54
status: NEW401 At the other end of the scale, the S1118F mutation might disrupt the stability of the protein global structure, leading to the observed effects on conduction.
X
ABCC7 p.Ser1118Phe 10866956:401:35
status: NEW405 The relative conductance of the S1118F-CFTR channel to large anions decreases during the course of the relaxations, which may indicate that either the large anions are more capable of blocking the channels in the steady-state conformation, or that Clafa; permeation becomes blocked by an intrinsic portion of the protein in the steady-state conformation.
X
ABCC7 p.Ser1118Phe 10866956:405:32
status: NEW418 The S1118F mutation may provide this reporter group in the form of the Phe side chain and/or slow the relaxations to a rate that is resolvable in macroscopic recordings.
X
ABCC7 p.Ser1118Phe 10866956:418:4
status: NEW
PMID: 23276700
[PubMed]
Krenkova P et al: "Distribution of CFTR mutations in the Czech population: positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations."
No.
Sentence
Comment
62
There are over 10 million inhabitants in the country, which according to population genetic analyses, is a representative of the CE ethnic composition [3], with significant overlaps with Table 1 (continued) Mutations/HGVS nomenclature/ Mutations/traditional nomenclature, legacy name/ Legacy exon/intron No. of alleles % 65. c.2290CNT R764X# Ex13 1 0.08 66. c.2490+1GNA 2622+1GNA# In13 1 0.08 67. c.2538GNA W846X*# Ex14a 1 0.08 68. c.2551CNT R851X# Ex14a 1 0.08 69. c.2589_2599delAATTTGGTGCT 2721del11 Ex14a 1 0.08 70. c.2705delG 2837delG Ex15 1 0.08 71. c.2789delG 2921delG Ex15 1 0.08 72. c.2803_2813delCTACCACTGGT 2935del11 Ex15 1 0.08 73. c.2856GNC M952I Ex15 1 0.08 74. c.2991GNC L997F# Ex17a 1 0.08 75. c.3106delA 3238delA Ex17a 1 0.08 76. c.3136GNT E1046X Ex17a 1 0.08 77. c.3139GNC G1047R Ex17a 1 0.08 78. c.3196CNT R1066C*# Ex17b 1 0.08 79. c.3196CNG R1066G Ex17b 1 0.08 80. c.3302TNG M1101R Ex17b 1 0.08 81. c.3310GNA E1104K Ex17b 1 0.08 82. c.3353CNT S1118F Ex17b 1 0.08 83. c.3472CNT R1158X*# Ex19 1 0.08 84. c.3587CNG S1196X# Ex19 1 0.08 85. c.3708delT 3840delT Ex19 1 0.08 86. c.3937CNT Q1313X# Ex21 1 0.08 87. c.3971TNC L1324P Ex22 1 0.08 88. c.4003CNT L1335F Ex22 1 0.08 89. c.4004TNC L1335P Ex22 1 0.08 90. c.4097TNA I1366N Ex22 1 0.08 91. c.4426CNT Q1476X Ex24 1 0.08 92.
X
ABCC7 p.Ser1118Phe 23276700:62:962
status: NEW
PMID: 23955087
[PubMed]
Wang W et al: "Relative contribution of different transmembrane segments to the CFTR chloride channel pore."
No.
Sentence
Comment
209
Previously, it was shown that substitution of S1118 with a much larger phenylalanine residue (S1118F) caused a larger (~35 %) decrease in single channel conductance [46].
X
ABCC7 p.Ser1118Phe 23955087:209:94
status: NEW